Hedera-22 develps a DNA-based synthesis platform combined with an enhanced predictive bioinformatics platform that will drastically increase the production, diversity and maturity of unique metabolites.
About
Join us
Become a BioWin member today and benefit from improved networking and industry intelligence in the life sciences and health sector.